Vivos Therapeutics (VVOS) Free Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 46.58% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 36.52% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 189.47% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 109.75% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 37.21% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 15.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.57% |
| Mar 31, 2026 | -53.70% |
| Dec 31, 2025 | -166.72% |
| Sep 30, 2025 | 6.26% |
| Jun 30, 2025 | -35.85% |
| Mar 31, 2025 | -47.06% |
| Dec 31, 2024 | -5.29% |
| Sep 30, 2024 | -48.68% |
| Jun 30, 2024 | -1.22% |
| Mar 31, 2024 | 29.41% |
| Dec 31, 2023 | 9.03% |
| Sep 30, 2023 | 50.39% |
| Jun 30, 2023 | 39.68% |
| Mar 31, 2023 | 39.26% |
| Dec 31, 2022 | 28.95% |
| Sep 30, 2022 | -33.70% |
| Jun 30, 2022 | -2.75% |
| Mar 31, 2022 | -49.45% |
| Dec 31, 2021 | -20.65% |
| Sep 30, 2021 | -548.85% |